is allulose a glp 1 agonist GLP1 Does Allulose Boost GLP-1 Levels?

Outcomes in GLP-1 RA-Experienced Patients Switching to Once-Weekly Semaglutide in a Real-World Setting: The Retrospective, Observational EXPERT Study

In general, without knowing what Medicaid and Medicare generally are currently paying for these drugs on net, it is uncertain whether the lower prices that will be made available to state Medicaid programs and Part D plans under the BALANCE Model for currently covered uses of GLP-1s will generate enough savings to offset the additional costs from expanded use of these medications for obesity

Chen G, Yu J, Gu Z

Side effects with current GLP-1 drugs are attributed to the triggering of alternative pathways

In the future, we will link our findings to patient-level claims data to understand how prior authorization design affect medication initiation, adherence, and patient outcomes